| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.06. | GSK runs first DTC ad for would-be asthma blockbuster Exdensur | ||
| 17.06. | Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports | ||
| 17.06. | Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility | ||
| 17.06. | After FDA sign-off, Colorado's drug import plan faces tough road ahead | ||
| 16.06. | FDA, UK drug regulator deepen transatlantic ties with new liaison program | ||
| 16.06. | DeepIntent gives Helix an AI twist to help marketers query data | ||
| 16.06. | Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom | ||
| 16.06. | Recipharm channels 'multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand | ||
| 16.06. | Stealth BioTherapeutics removes cloak to become Mighty | ||
| 16.06. | PhRMA talks up the power of 'Medicines First' in new campaign | ||
| 15.06. | Germany backs off plan to install variable discount pricing on drugs: report | ||
| 15.06. | Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod | ||
| 15.06. | IQVIA taps AI to put overlooked prescribers on marketers' maps | ||
| 15.06. | Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield | ||
| 15.06. | Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion | ||
| 12.06. | FDA hearing on Amgen's Tavneos will include findings from an independent review | ||
| 12.06. | In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test | ||
| 12.06. | Lilly, Biogen, Eisai and Genentech sponsor new 'Let's Talk Alzheimer's' podcast | ||
| 11.06. | Genentech executes another round of layoffs, with 3 VPs axed | ||
| 11.06. | Novo reports data breach, tells clinical trial patients to 'remain vigilant' | ||
| 11.06. | J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win | ||
| 11.06. | Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure | ||
| 11.06. | Madrigal takes giant inflatable liver on US tour in disease awareness push | ||
| 11.06. | Olixir NY teams with Crohn's & Colitis Foundation for 'Spill Your Guts' campaign | ||
| 10.06. | Genentech and Novartis dish up food allergy microdrama series |